Multi-Task Adversarial Learning for Treatment Effect Estimation in Basket Trials

• URL: http://arxiv.org/abs/2203.05123v1
• Date: Thu, 10 Mar 2022 02:41:26 GMT
• Title: Multi-Task Adversarial Learning for Treatment Effect Estimation in Basket Trials
• Authors: Zhixuan Chu, Stephen L. Rathbun, Sheng Li
• Abstract summary: We describe causal inference for application in a novel clinical design called basket trial. We propose a multi-task adversarial learning (MTAL) method to estimate potential outcomes across different tumor types.
• Score: 12.266020657495618
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Estimating treatment effects from observational data provides insights about causality guiding many real-world applications such as different clinical study designs, which are the formulations of trials, experiments, and observational studies in medical, clinical, and other types of research. In this paper, we describe causal inference for application in a novel clinical design called basket trial that tests how well a new drug works in patients who have different types of cancer that all have the same mutation. We propose a multi-task adversarial learning (MTAL) method, which incorporates feature selection multi-task representation learning and adversarial learning to estimate potential outcomes across different tumor types for patients sharing the same genetic mutation but having different tumor types. In our paper, the basket trial is employed as an intuitive example to present this new causal inference setting. This new causal inference setting includes, but is not limited to basket trials. This setting has the same challenges as the traditional causal inference problem, i.e., missing counterfactual outcomes under different subgroups and treatment selection bias due to confounders. We present the practical advantages of our MTAL method for the analysis of synthetic basket trial data and evaluate the proposed estimator on two benchmarks, IHDP and News. The results demonstrate the superiority of our MTAL method over the competing state-of-the-art methods.

Related papers

• Detecting critical treatment effect bias in small subgroups [11.437076464287822]
  We propose a novel strategy to benchmark observational studies beyond the average treatment effect. First, we design a statistical test for the null hypothesis that the treatment effects estimated from the two studies, conditioned on a set of relevant features, differ up to some tolerance. We then estimate anally valid lower bound on the maximum bias strength for any subgroup in the observational study.
  arXiv  Detail & Related papers  (2024-04-29T17:44:28Z)
• The Blessings of Multiple Treatments and Outcomes in Treatment Effect Estimation [53.81860494566915]
  Existing studies leveraged proxy variables or multiple treatments to adjust for confounding bias. In many real-world scenarios, there is greater interest in studying the effects on multiple outcomes. We show that parallel studies of multiple outcomes involved in this setting can assist each other in causal identification.
  arXiv  Detail & Related papers  (2023-09-29T14:33:48Z)
• SPOT: Sequential Predictive Modeling of Clinical Trial Outcome with Meta-Learning [67.8195828626489]
  Clinical trials are essential to drug development but time-consuming, costly, and prone to failure. We propose Sequential Predictive mOdeling of clinical Trial outcome (SPOT) that first identifies trial topics to cluster the multi-sourced trial data into relevant trial topics. With the consideration of each trial sequence as a task, it uses a meta-learning strategy to achieve a point where the model can rapidly adapt to new tasks with minimal updates.
  arXiv  Detail & Related papers  (2023-04-07T23:04:27Z)
• Learning to Infer Counterfactuals: Meta-Learning for Estimating Multiple Imbalanced Treatment Effects [41.06974193338288]
  We consider data episodes among treatment groups in counterfactual inference as meta-learning tasks. We train a meta-learner from a set of source treatment groups with sufficient samples and update the model by gradient descent with limited samples in target treatment. We perform experiments on two real-world datasets to evaluate inference accuracy and generalization ability.
  arXiv  Detail & Related papers  (2022-08-13T23:22:12Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• A method for comparing multiple imputation techniques: a case study on the U.S. National COVID Cohort Collaborative [1.259457977936316]
  We numerically evaluate strategies for handling missing data in the context of statistical analysis. Our approach could effectively highlight the most valid and performant missing-data handling strategy.
  arXiv  Detail & Related papers  (2022-06-13T19:49:54Z)
• Ensemble Method for Estimating Individualized Treatment Effects [15.775032675243995]
  We propose an algorithm for aggregating the estimates from a diverse library of models. We compare ensembling to model selection on 43 benchmark datasets, and find that ensembling wins almost every time.
  arXiv  Detail & Related papers  (2022-02-25T00:44:37Z)
• SurvITE: Learning Heterogeneous Treatment Effects from Time-to-Event Data [83.50281440043241]
  We study the problem of inferring heterogeneous treatment effects from time-to-event data. We propose a novel deep learning method for treatment-specific hazard estimation based on balancing representations.
  arXiv  Detail & Related papers  (2021-10-26T20:13:17Z)
• Personalized pathology test for Cardio-vascular disease: Approximate Bayesian computation with discriminative summary statistics learning [48.7576911714538]
  We propose a platelet deposition model and an inferential scheme to estimate the biologically meaningful parameters using approximate computation. This work opens up an unprecedented opportunity of personalized pathology test for CVD detection and medical treatment.
  arXiv  Detail & Related papers  (2020-10-13T15:20:21Z)
• A Machine Learning alternative to placebo-controlled clinical trials upon new diseases: A primer [0.0]
  A new dangerous and contagious disease requires the development of a drug therapy faster than what is foreseen by usual mechanisms. We compare a new technique in which all patients receive a different and reasonable combination of drugs and use this outcome to feed a Neural Network. By averaging out fluctuations and recognizing different patient features, the Neural Network learns the pattern that connects the patients initial state to the outcome of the treatments.
  arXiv  Detail & Related papers  (2020-03-26T17:53:10Z)
• Generalization Bounds and Representation Learning for Estimation of Potential Outcomes and Causal Effects [61.03579766573421]
  We study estimation of individual-level causal effects, such as a single patient's response to alternative medication. We devise representation learning algorithms that minimize our bound, by regularizing the representation's induced treatment group distance. We extend these algorithms to simultaneously learn a weighted representation to further reduce treatment group distances.
  arXiv  Detail & Related papers  (2020-01-21T10:16:33Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.